Market access of gene therapies across Europe, USA, and Canada: challenges, trends, and solutions.


Journal

Drug discovery today
ISSN: 1878-5832
Titre abrégé: Drug Discov Today
Pays: England
ID NLM: 9604391

Informations de publication

Date de publication:
02 2021
Historique:
received: 10 08 2020
revised: 21 10 2020
accepted: 19 11 2020
pubmed: 27 11 2020
medline: 15 12 2021
entrez: 26 11 2020
Statut: ppublish

Résumé

This review can inform gene therapy developers on challenges that can be encountered when seeking market access. Moreover, it provides an overview of trends among challenges and potential solutions.

Identifiants

pubmed: 33242695
pii: S1359-6446(20)30508-0
doi: 10.1016/j.drudis.2020.11.024
pii:
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

399-415

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Auteurs

Eline van Overbeeke (E)

Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, 3000 Leuven, Belgium. Electronic address: eline.vanoverbeeke@kuleuven.be.

Sissel Michelsen (S)

Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, 3000 Leuven, Belgium; Healthcare Management Centre, Vlerick Business School, Reep 1, 9000 Ghent, Belgium.

Mondher Toumi (M)

Public Health Department, Aix Marseille University, 27 bd Jean Moulin, Marseille, France.

Hilde Stevens (H)

Institute for Interdisciplinary Innovation in Healthcare (I(3)h), Université libre de Bruxelles, Route de Lennik 808, Brussels, Belgium.

Mark Trusheim (M)

Massachusetts Institute of Technology, 100 Main Street, Cambridge, MA 02139, USA.

Isabelle Huys (I)

Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, 3000 Leuven, Belgium.

Steven Simoens (S)

Clinical Pharmacology and Pharmacotherapy, University of Leuven, Herestraat 49 Box 521, 3000 Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH